These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29544975)

  • 21. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.
    Plewan A; Lehmann G; Ndrepepa G; Schreieck J; Alt EU; Schömig A; Schmitt C
    Eur Heart J; 2001 Aug; 22(16):1504-10. PubMed ID: 11482924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pharmacokinetic comparison of generic tablets containing bisoprolol with the innovator formulation in healthy volunteers.
    Jovanović D; Cusić S; Rancić D; Srnić D; Perković-Vukcević N
    J Clin Pharmacol; 2006 Oct; 46(10):1217-22. PubMed ID: 16988212
    [No Abstract]   [Full Text] [Related]  

  • 23. Severe sinus bradycardia after initiation of bupropion therapy: a probable drug-drug interaction with metoprolol.
    McCollum DL; Greene JL; McGuire DK
    Cardiovasc Drugs Ther; 2004 Jul; 18(4):329-30. PubMed ID: 15367832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ; Heaton PC; Cluxton RJ
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.
    Stoschitzky K; Stoschitzky G; Brussee H; Bonelli C; Dobnig H
    Cardiology; 2006; 106(4):199-206. PubMed ID: 16679760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amiodarone-associated "torsade de pointes". Relevance of concomitant cardiovascular medication in a patient with atrial fibrillation and structural heart disease.
    Schrickel J; Bielik H; Yang A; Schwab JO; Shlevkov N; Schimpf R; Lüderitz B; Lewalter T
    Z Kardiol; 2003 Oct; 92(10):889-92. PubMed ID: 14579055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are we misunderstanding beta-blockers.
    Cruickshank JM
    Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of bisoprolol treatment for chronic heart failure initiated and followed up by primary care physicians.
    Schuchert A;
    Eur J Heart Fail; 2005 Jun; 7(4):604-11. PubMed ID: 15921801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study.
    Sezai A; Nakai T; Hata M; Yoshitake I; Shiono M; Kunimoto S; Hirayama A
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1241-8. PubMed ID: 22858430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.
    Marazzi G; Iellamo F; Volterrani M; Caminiti G; Madonna M; Arisi G; Massaro R; Righi D; Rosano GM
    Am J Cardiol; 2011 Jan; 107(2):215-9. PubMed ID: 21129714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereoselective pharmacokinetics of bisoprolol after intravenous and oral administration in beagle dogs.
    Horikiri Y; Suzuki T; Mizobe M
    J Pharm Sci; 1997 May; 86(5):560-4. PubMed ID: 9145379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of prophylactic bisoprolol plus magnesium on the incidence of atrial fibrillation after coronary bypass surgery: results of a randomized controlled trial.
    Behmanesh S; Tossios P; Homedan H; Hekmat K; Hellmich M; Müller-Ehmsen J; Schwinger RH; Mehlhorn U
    Curr Med Res Opin; 2006 Aug; 22(8):1443-50. PubMed ID: 16870070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.
    Beddies G; Fox PR; Papich MD; Kanikanti VR; Krebber R; Keene BW
    Am J Vet Res; 2008 Dec; 69(12):1659-63. PubMed ID: 19046015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adverse effects and toxicity of beta blockers].
    Bosković B; Dobrić S; Stojiljković MP
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():74-80. PubMed ID: 18193817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-rated health predicts adverse events during β-blocker treatment: the CIBIS-ELD randomised trial analysis.
    Lainscak M; Farkas J; Inkrot S; Gelbrich G; Neskovic AN; Rau T; Tahirovic E; Töpper A; Apostolovic S; Haverkamp W; Herrmann-Lingen C; Anker SD; Düngen HD
    Int J Cardiol; 2013 Feb; 163(1):87-92. PubMed ID: 21652093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of beta-blockers in heart failure].
    Inoko M; Nohara R
    Nihon Rinsho; 2003 May; 61(5):816-20. PubMed ID: 12755008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sotalol--atrial fibrillation, reduced renal function and sudden death].
    Bathen J; Madsen S
    Tidsskr Nor Laegeforen; 1998 Oct; 118(26):4086-7. PubMed ID: 9844513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptomatic bradycardia induced by the combination of oral diltiazem and beta blockers.
    Sagie A; Strasberg B; Kusnieck J; Sclarovsky S
    Clin Cardiol; 1991 Apr; 14(4):314-6. PubMed ID: 1674455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.